Guilongwan Ameliorates Experimental Diabetic Foot Ulcer in Rats via the Inhibition of Delta‐Like 4/Notch1 Signaling in M1 Macrophages
Advanced Biology · 2025-09 · 9 (9)
DOI: 10.1002/adbi.202400819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Biology, online erschienen am 19.05.2025. Verfasst von Xi-Ting Lv und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, China. Hauptthemen laut MEDLINE: Diabetic Foot, Receptor, Notch1, Macrophages, Drugs, Chinese Herbal. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Guangzhou Basic and Applied Basic Research-Municipal and School (College) Joint Foundation, National Natural Science Foundation of China.
Themen: Diabetisches Fußsyndrom
Abstract (Originalsprache)
Guilongwan (GLW), a representative of traditional Chinese Medicine (TCM) has been utilized to treating diabetic foot ulcer (DFU)‐related syndrome including an intolerance of cold with cold limbs, blood circulation disorder, and immune dysfunction for decades. However, the chemical and biological mechanisms of GLW remain unclear. This study aims to discover the biological mechanisms of GLW on DFU by using streptozotocin‐ and skin‐puncher‐induced DFU rat models, in vitro macrophage models, and in silico analysis. The alterations in pathology, Notch1 signaling, and macrophage polarization are detected. The results indicated that GLW promoted wound healing, cutaneous cell proliferation, and angiogenesis in DFU rats by inhibiting delta‐like (DLL) 4/Notch1 signaling. In addition, GLW inhibited M1 polarization and promoted M2 polarization in diabetic wounds. Seventeen chemical compounds in GLW‐medicated serum are identified. In silico analysis and in vitro experiments demonstrated that GLW‐medicated serum and its main compounds inhibited the expression of DLL4 in matrix metalloproteinase‐9‐induced M1 macrophages. In conclusion, GLW ameliorated experimental DFU rats via the inhibition of DLL4/Notch1 signaling in M1 macrophages. This study provided a new biologic mechanism for GLW in the treatment of DFU.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
- The Affiliated Traditional Chinese Medicine Hospital of Guangzhou Medical University, Guangzhou, 510130, China.
ORCID-Profile: Guo-En Wang
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangzhou Basic and Applied Basic Research-Municipal and School (College) Joint Foundation
- National Natural Science Foundation of China
- Research Project of Administration of Traditional Chinese Medicine of Guangdong Province
Zitieren
APA
Lv, X. T., Yang, W. X., Zhang, X., Li, B. L., Wang, W. Y., & Wang, G. E. (2025). Guilongwan Ameliorates Experimental Diabetic Foot Ulcer in Rats via the Inhibition of Delta‐Like 4/Notch1 Signaling in M1 Macrophages. Advanced Biology, 9(9). https://doi.org/10.1002/adbi.202400819
Vancouver
Lv XT, Yang WX, Zhang X, Li BL, Wang WY, Wang GE. Guilongwan Ameliorates Experimental Diabetic Foot Ulcer in Rats via the Inhibition of Delta‐Like 4/Notch1 Signaling in M1 Macrophages. Advanced Biology. 2025;9(9). doi:10.1002/adbi.202400819
BibTeX
@article{Lv2025,
author = {Lv, Xi-Ting and Yang, Wen-Xiu and Zhang, Xiao and Li, Bao-Ling and Wang, Wen-Ying and Wang, Guo-En},
title = {Guilongwan Ameliorates Experimental Diabetic Foot Ulcer in Rats via the Inhibition of Delta‐Like 4/Notch1 Signaling in M1 Macrophages},
journal = {Advanced Biology},
year = {2025},
volume = {9},
number = {9},
doi = {10.1002/adbi.202400819}
}
EUVIMED